Correlation Between Ikena Oncology and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and MAIA Biotechnology, you can compare the effects of market volatilities on Ikena Oncology and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and MAIA Biotechnology.
Diversification Opportunities for Ikena Oncology and MAIA Biotechnology
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ikena and MAIA is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Ikena Oncology and MAIA Biotechnology
Given the investment horizon of 90 days Ikena Oncology is expected to under-perform the MAIA Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Ikena Oncology is 1.12 times less risky than MAIA Biotechnology. The stock trades about -0.03 of its potential returns per unit of risk. The MAIA Biotechnology is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 247.00 in MAIA Biotechnology on August 31, 2024 and sell it today you would lose (26.00) from holding MAIA Biotechnology or give up 10.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ikena Oncology vs. MAIA Biotechnology
Performance |
| Timeline |
| Ikena Oncology |
| MAIA Biotechnology |
Ikena Oncology and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ikena Oncology and MAIA Biotechnology
The main advantage of trading using opposite Ikena Oncology and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Eliem Therapeutics |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |